Australia markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6800+0.0100 (+1.49%)
At close: 04:00PM EDT
0.6850 +0.00 (+0.74%)
After hours: 07:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 336.80M
Enterprise value 98.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.16
Price/book (mrq)1.18
Enterprise value/revenue 0.05
Enterprise value/EBITDA -0.47

Trading information

Stock price history

Beta (5Y monthly) 1.85
52-week change 3-12.82%
S&P500 52-week change 322.36%
52-week high 31.6300
52-week low 30.6060
50-day moving average 30.7824
200-day moving average 30.9998

Share statistics

Avg vol (3-month) 39.3M
Avg vol (10-day) 34.61M
Shares outstanding 5405.64M
Implied shares outstanding 6495.29M
Float 8375.05M
% held by insiders 17.38%
% held by institutions 124.45%
Shares short (15 Apr 2024) 448.16M
Short ratio (15 Apr 2024) 45.42
Short % of float (15 Apr 2024) 411.94%
Short % of shares outstanding (15 Apr 2024) 49.72%
Shares short (prior month 15 Mar 2024) 447.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -10.48%
Operating margin (ttm)-10.35%

Management effectiveness

Return on assets (ttm)-16.98%
Return on equity (ttm)-66.33%

Income statement

Revenue (ttm)2.04B
Revenue per share (ttm)4.22
Quarterly revenue growth (yoy)-44.30%
Gross profit (ttm)N/A
EBITDA -186.08M
Net income avi to common (ttm)-213.36M
Diluted EPS (ttm)-0.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)242.68M
Total cash per share (mrq)0.49
Total debt (mrq)4.66M
Total debt/equity (mrq)1.63%
Current ratio (mrq)1.64
Book value per share (mrq)0.59

Cash flow statement

Operating cash flow (ttm)-115.87M
Levered free cash flow (ttm)71.6M